Voip-Pal.com Inc. Receives New Patent As it Awaits Decision of the PTAB
April 17, 2018 05:00 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., April 17, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB:VPLM) is pleased to announce that it was issued U.S. Patent No. 9,948,549 today. Following...
DIGITAL ALLY, INC. ANNOUNCES 2017 OPERATING RESULTS
April 13, 2018 08:00 ET
|
Digital Ally Inc.
Updates Strategic Review Process and Litigation Status LENEXA, Kansas, April 13, 2018 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY), which develops, manufactures and markets advanced video...
Voip-Pal.com Inc. Strengthens the Breadth and Depth of Its Patent Holdings
April 12, 2018 05:00 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., April 12, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB:VPLM) continues to have success in strengthening its worldwide patent portfolio. “The Company’s...
Voip-Pal.com Inc. Receives Issue Notifications for Two New Continuation Patents for its Routing, Billing and Rating Technology
April 03, 2018 05:00 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., April 03, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB:VPLM) is pleased to announce that it has received issue notifications from the United States...
CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
February 21, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) --
AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News...
Court Date Set for Worlds Inc.’s IPR Appeal Oral Argument
January 25, 2018 08:00 ET
|
Worlds Inc.
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) announced that on January 22, 2018, the United States Court of Appeals for the Federal Circuit scheduled the oral argument for...
Voip-Pal Issues a Correction to its Press Release of September 18th 2017
January 11, 2018 22:36 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Voip-Pal.com, Inc. (“Voip-Pal,” the “Company”) (OTCQB:VPLM) has posted a series of letters authored by former Chairman and CEO, Dr. Thomas Sawyer,...
PROVECTUS BIOPHARMACEUTICALS RECEIVES THIRD CANCER COMBINATION THERAPY PATENT FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE
December 14, 2017 06:00 ET
|
Provectus Biopharmaceuticals Inc.
– Protection expands coverage for combinations of intralesional PV-10 with checkpoint inhibitors for multiple solid tumor cancers – KNOXVILLE, TN, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Provectus...
New U.S. Patent Allowance Granted to AXIM® Biotechnologies, Inc. for Cannabinoid Ophthalmic Solutions for Glaucoma and Conjunctivitis Treatment
October 05, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Oct. 05, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States...
Voip-Pal.Com Posts Letters from Former Chairman, Dr. Thomas Sawyer on Company Website
September 18, 2017 05:00 ET
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Voip-Pal.com, Inc. (“Voip-Pal,” the “Company”) (OTCQB:VPLM) has posted a series of letters authored by former Chairman and CEO, Dr. Thomas...